The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 30, 2025 for Aayush Agrawal, ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts more than Nifty Midcap 150 and 1.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aayush Agrawal, a promoter of Ajanta Pharma, has created a pledge on a total of 16,02,500 shares (approximately 1.28% of total share capital). The pledge creation happened on December 24, 2025, and involves two separate pledges: 11,25,000 shares (0.90%) pledged to RBL Bank Ltd for a Bank Guarantee, and 4,77,500 shares (0.38%) pledged to Bajaj Finance Ltd for an increased loan. After this event, Aayush Agrawal's total encumbered shares stand at 81,20,747 shares, or 6.50% of total share capital. The promoter Aayush Agrawal Trust holds 1,41,12,924 shares (11.30%) in total.
This is a routine promoter pledge creation for personal borrowing needs (bank guarantee and loan increase). The pledged shares represent a relatively small portion of the promoter's total holding, so the immediate risk to shareholders is limited. Investors should monitor if pledge sizes grow significantly or if any invocation events follow.